Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: What have we learnt from the past – would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?

Fig. 3

Kaplan Meier estimator for median OS of GEP-NET patients according to primary site [6]. Notes: We were not able to investigate median OS of gastric NET patients and patients with appendix NET, due to the fact that less than 50% of these patients died until the end of the observation period. The single patient with NET of the gallbladder was extracted from illustration due to lack of statistical power. Median OS over all patients was 181 months (95% CI, 106 – 256 months). Abbreviations: CI, confidence interval; GEP, gastroenteropancreatic; NET, neuroendocrine tumor; OS, overall survival

Back to article page